Asp Isotopes INC Form 4 insider transactions

ASP Isotopes Inc. Director Todd Wider was granted 36,548 shares of common stock as an annual award for his service.

ASP Isotopes Inc. Director Robert John Andrew Ryan acquired 36,548 shares of common stock as an annual restricted stock award, increasing his beneficial ownership to 652,222 shares.

ASP Isotopes Inc. Director Ralph L. Hunter Jr. was awarded 36,548 shares of restricted stock, effective December 18, 2025, as part of his annual compensation.

ASP Isotopes Inc. Director Michael Gorley received an annual award of 36,548 shares of restricted common stock, increasing his beneficial ownership to 117,908 shares.

ASP Isotopes Inc.'s Interim CEO and COO, Robert Ainscow, sold 8,438 shares of common stock at a weighted average price of $6.203 to cover tax withholding obligations.

ASP Isotopes Inc.'s Executive Chairman, Paul Elliot Mann, sold 162,153 shares of common stock on December 1, 2025, to cover tax withholding obligations under a pre-arranged 10b5-1 trading plan.

ASP Isotopes Inc. director Ralph L. Hunter Jr. acquired 10,470 shares of common stock valued at $100,000 as part of his compensation for joining the board.

ASP Isotopes Inc. granted Executive Vice President, General Counsel, and Secretary Donald Ainscow 400,000 shares of common stock effective August 1, 2025, as part of his appointment.

Robert Ainscow, Interim CEO and COO of ASP Isotopes Inc., sold 25,000 shares of common stock on November 25, 2025, at a weighted average price of $5.769 per share.

ASP Isotopes Inc. Director and Executive Officer Paul Elliot Mann sold a total of 162,500 shares of common stock in two separate transactions in November 2025.

ASP Isotopes Inc.'s Interim CEO and COO, Robert Ainscow, sold 67,500 shares of common stock at a weighted average price of $7.507 to cover tax withholding obligations.

ASP Isotopes Inc. director Todd Wider received an award of 25,469 shares of common stock for his service on the QLE Structuring and Strategic Transactions Committee.

ASP Isotopes Inc.'s Interim CEO and COO, Robert Ainscow, sold 22,500 shares of common stock to cover tax withholding obligations related to restricted stock awards.

ASP Isotopes Director Todd Wider exercised stock options and subsequently sold shares to cover tax liabilities and for personal liquidity.

ASP Isotopes Director Michael Gorley sold 64,000 shares of common stock at a weighted average price of $9.7537 to cover tax liabilities from vested restricted stock awards.

ASP Isotopes Inc.'s Chief Operating Officer, Robert Ainscow, reported significant changes in his beneficial ownership, including option exercises and stock sales for tax obligations.

ASP Isotopes CEO Paul Mann exercised stock options and sold shares for tax purposes under a 10b5-1 plan, increasing his net beneficial ownership.

ASP Isotopes Inc. Director Duncan Moore sold 75,000 shares of common stock to cover tax liabilities from a restricted stock award vesting.

Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc., executed sales of common stock between April 15 and April 17, 2025, under a pre-arranged Rule 10b5-1 trading plan.

ASP Isotopes CEO Paul Mann sold a total of 950,000 shares of common stock over three days, as disclosed in a Form 4 filing with the SEC.

Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc., acquired 400,000 shares of common stock on April 14, 2025, increasing his total holdings to 1,619,992 shares.

Heather Kiessling, CFO of ASP Isotopes Inc., reports acquiring 400,000 shares of common stock on April 14, 2025.

Paul Elliot Mann, CEO of ASP Isotopes Inc., reports the acquisition of 1,441,361 shares of common stock on April 14, 2025, increasing his total holdings to 8,265,454 shares.

ASP Isotopes Inc. awarded common stock to an independent director, Donald Ainscow, in place of quarterly cash fees.

Director Todd Wider acquired 42,522 shares of ASP Isotopes Inc. common stock as part of an annual award for service.

Director Duncan Moore of ASP Isotopes Inc. received 42,522 shares of common stock as an annual award for his service.

Director Robert John Andrew Ryan acquired 42,522 shares of ASP Isotopes Inc. common stock as part of an annual award for his service.

Director Michael Gorley of ASP Isotopes Inc. received 42,522 shares of common stock as an annual award.

AK Jensen Investment Management Ltd, a 10% owner of ASP Isotopes Inc., reports the acquisition of 30,000 shares at a weighted average price of $3.0256.

Robert Ainscow, Chief Operating Officer of ASP Isotopes Inc., acquired 300,000 shares of common stock on September 6, 2024, bringing his total holdings to 1,219,992 shares.